Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00274391Phase 2Completed
Phase 2 trial of amiloride in cystic fibrosis (CF) (2 arms). Primary endpoint: Forced Expiratory Volume in 1 second. Started Jul 2001; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00274391.